Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32349935.
- Also identified by DOI 10.1016/j.eururo.2020.04.027 and PMC identifier 7172651.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The current World Health Organization guidance is not to start corticosteroids, but there is no robust evidence of risk in patients with cancer and coronavirus disease 2019. A risk-benefit analysis should be performed for each patient on the use of steroids in cancer care.
Medical subject headings
- Adrenal Cortex Hormones
- Coronavirus Infections
- Pneumonia, Viral
- Practice Guidelines as Topic
- Urologic Neoplasms